Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fartoux

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Nephrologie & Therapeutique|January 31, 2017
L Fartoux
Nephrologie & Therapeutique|January 31, 2017
P Brunet, L Fartoux
Clinics and Research in Hepatology and Gastroenterology|February 14, 2012
HCC and NASH: how strong is the clinical demonstration?O Rosmorduc, L Fartoux
Gastroenterologie Clinique Et Biologique|March 18, 2008
[Targeted HCC therapies: the door has been opened!]O Rosmorduc, L Fartoux
Nephrologie & Therapeutique|January 31, 2017
F Vrtovsnik, L Fartoux
Nephrologie & Therapeutique|January 31, 2017
C Chazot, L Fartoux
Nephrologie & Therapeutique|January 31, 2017
J-P Bourdenx, L Fartoux
Annales De Medecine Interne|October 11, 2001
[Acute hepatitis and drug dermatitis due to fenofibrate (Secalip)]L Fartoux-Heymann, B Narcy-Lambare, D Labayle, et al.
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Bacterial translocation in colchicine poisoning]M Alzieu, L Fartoux, J Zuber, et al.
Journal of Hepatology|November 3, 2001
Acute fatal hepatitis related to sertralineL Fartoux-Heymann, C Hézode, E S Zafrani, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nephrologie & Therapeutique|January 31, 2017
L Fartoux
Nephrologie & Therapeutique|January 31, 2017
P Brunet, L Fartoux
Clinics and Research in Hepatology and Gastroenterology|February 14, 2012
HCC and NASH: how strong is the clinical demonstration?O Rosmorduc, L Fartoux
Gastroenterologie Clinique Et Biologique|March 18, 2008
[Targeted HCC therapies: the door has been opened!]O Rosmorduc, L Fartoux
Nephrologie & Therapeutique|January 31, 2017
F Vrtovsnik, L Fartoux
Nephrologie & Therapeutique|January 31, 2017
C Chazot, L Fartoux
Nephrologie & Therapeutique|January 31, 2017
J-P Bourdenx, L Fartoux
Annales De Medecine Interne|October 11, 2001
[Acute hepatitis and drug dermatitis due to fenofibrate (Secalip)]L Fartoux-Heymann, B Narcy-Lambare, D Labayle, et al.
Presse Medicale (Paris, France : 1983)|October 16, 1999
[Bacterial translocation in colchicine poisoning]M Alzieu, L Fartoux, J Zuber, et al.
Journal of Hepatology|November 3, 2001
Acute fatal hepatitis related to sertralineL Fartoux-Heymann, C Hézode, E S Zafrani, et al.
Pageof 2